A novel small‐molecule activator of procaspase‐3 induces apoptosis in cancer cells and reduces tumor growth in human breast, liver and gallbladder cancer xenografts

Procaspase‐3, a proenzyme of apoptotic executioner caspase‐3, is overexpressed in numerous tumors. We aimed to characterize a novel procaspase‐3 activator, WF‐210, which may have potential as an anticancer drug.

[1]  H. Kashkar.  X-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise , 2010, Clinical Cancer Research.

[2]  X. Liu,et al.  Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma , 2004, Biological chemistry.

[3]  Chunfu Wu,et al.  Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  Tao Yang,et al.  Anti-cancer drug induced neurotoxicity and identification of Rho pathway signaling modulators as potential neuroprotectants. , 2008, Neurotoxicology.

[5]  P. Hergenrother,et al.  PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition. , 2009, Journal of molecular biology.

[6]  A. Schimmer.  Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice , 2004, Cancer Research.

[7]  Pascal Meier,et al.  IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer , 2010, Nature Reviews Cancer.

[8]  P. Hergenrother,et al.  Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3. , 2009, Journal of medicinal chemistry.

[9]  D. Altieri.  Survivin and IAP proteins in cell-death mechanisms. , 2010, The Biochemical journal.

[10]  H. Pehamberger,et al.  Elevated procaspase levels in human melanoma , 2001, Melanoma research.

[11]  Fan Zhou,et al.  Seed Oil of Brucea javanica Induces Apoptotic Death of Acute Myeloid Leukemia Cells via Both the Death Receptors and the Mitochondrial-Related Pathways , 2011, Evidence-based complementary and alternative medicine : eCAM.

[12]  Niall O'Higgins,et al.  Caspase 3 in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  S. Storey.  Targeting apoptosis: selected anticancer strategies , 2008, Nature Reviews Drug Discovery.

[14]  Chunfu Wu,et al.  Direct in vivo evidence of protective effects of grape seed procyanidin fractions and other antioxidants against ethanol-induced oxidative DNA damage in mouse brain cells. , 2007, Journal of agricultural and food chemistry.

[15]  A. Thor,et al.  Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-α induced apoptosis , 2006, Apoptosis.

[16]  Jong-Wan Park,et al.  Survivin mediates prostate cell protection by HIF‐1α against zinc toxicity , 2010, The Prostate.

[17]  E. Crawford,et al.  Caspase substrates and cellular remodeling. , 2011, Annual review of biochemistry.

[18]  T. Fan,et al.  Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound. , 2010, Cancer research.

[19]  Yigong Shi.  Caspase Activation Revisiting the Induced Proximity Model , 2004, Cell.

[20]  Tsung-Teh Wu,et al.  Overexpression of caspase-3 in hepatocellular carcinomas , 2004, Modern Pathology.

[21]  S. Alkan,et al.  Characterization of the Interleukin-1β-Converting Enzyme/Ced-3-Family Protease, Caspase-3/CPP32, in Hodgkin's Disease: Lack of Caspase-3 Expression in Nodular Lymphocyte Predominance Hodgkin's Disease , 1999 .

[22]  G. Salvesen,et al.  Human Caspases: Activation, Specificity, and Regulation* , 2009, The Journal of Biological Chemistry.

[23]  R. Paulsen,et al.  Procaspase-activating compound 1 induces a caspase-3-dependent cell death in cerebellar granule neurons. , 2010, Toxicology and applied pharmacology.

[24]  Chaohong Sun,et al.  Regulation of the Apaf-1/Caspase-9 Apoptosome by Caspase-3 and XIAP* , 2003, The Journal of Biological Chemistry.

[25]  M. Su,et al.  High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. , 1997, Cancer research.

[26]  Scott W. Lowe,et al.  Apoptosis A Link between Cancer Genetics and Chemotherapy , 2002, Cell.

[27]  A. Schimmer,et al.  Targeting the IAP family of caspase inhibitors as an emerging therapeutic strategy. , 2005, Hematology. American Society of Hematology. Education Program.

[28]  J. Prakash,et al.  Novel Polypyridyl chelators deplete cellular zinc and destabilize the X‐linked inhibitor of apoptosis protein (XIAP) prior to induction of apoptosis in human prostate and breast cancer cells , 2012, Journal of cellular biochemistry.

[29]  P. Hergenrother,et al.  Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy , 2006, Nature chemical biology.

[30]  D. Green.  Apoptotic Pathways Paper Wraps Stone Blunts Scissors , 2000, Cell.

[31]  Tsung-Teh Wu,et al.  Overexpression of caspase-3 in hepatocellular carcinomas , 2004, Modern Pathology.

[32]  Qiaojun He,et al.  GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1. , 2011, Cancer letters.

[33]  M. Hengartner.  The biochemistry of apoptosis , 2000, Nature.

[34]  R. Uzzo,et al.  Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis , 2008, Cell Death and Differentiation.

[35]  M. O’Connor-McCourt,et al.  Substrate cleavage by caspases generates protein fragments with Smac/Diablo-like activities , 2003, Cell Death and Differentiation.

[36]  R. Korneluk,et al.  The inhibitors of apoptosis: there is more to life than Bcl2 , 2003, Oncogene.

[37]  S. Sanchit.  V ARIOUS APPROACHES FOR SYNTHESIS OF OXADIAZOLE DERIVATIVES , 2011 .

[38]  Q. Dou,et al.  Clinical development of novel proteasome inhibitors for cancer treatment , 2009, Expert opinion on investigational drugs.